We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
Leon-nanodrugs is starting the co-development business in nanomedicine, leading the way in supergenerics and high-barrier generics. Managing partner Dr Wolfgang Beier answers World Pharmaceutical Frontiers’ questions.